Patent Assignment
Reel/Frame 059421/0725
Assignment of Assignor's Interest
Recorded: 2022-03-29
Pages: 5
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NORTH CAROLINA, 27703
Covered Property
(1)
Dosing Regimens for Oral Complement Factor D Inhibitors
Application:
17/630,692 →
Publication:
US US20220257556A1
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.